FORM OF amendment No. 1 to the Series F Warrant to purchase Common StockSeries F Warrant Amendment • April 29th, 2020 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 29th, 2020 Company Industry JurisdictionThis amendment No. 1 to the SERIES F WARRANT TO PURCHASE COMMON STOCK (This “agreement”) is made as of April 24, 2020, by and between Windtree Therapeutics, Inc., a Delaware corporation (the “Company”) and the undersigned holder (“Holder”). The Company and the Holder are sometimes referred to herein collectively as the “Parties” and individually as a “Party.”